Prime Cabinet Secretary Musalia Mudavadi has hailed the work of two Kenyan scientists leading the development of an innovative treatment for sickle cell disease in the United States. During a visit to Morgantown, West Virginia, Mudavadi met with Dr. Wycliffe Omwancha and Charles Otieno, the president and CEO of Yunigen Inc., respectively. The two scientists are spearheading the creation of Scedamin, a pediatric formulation of hydroxyurea aimed at transforming the treatment landscape for children with sickle cell disease.
Speaking after the meeting, Mudavadi praised the duo’s achievements, calling them “a testament to Kenya’s talent, determination, and global impact.” He highlighted the drug’s potential to dramatically improve the lives of children globally, especially in Africa where the disease is most prevalent. “No man is limited” captures the spirit of these brilliant Kenyan minds,” he noted.
Scedamin is specifically formulated for children aged nine months and above and is designed to overcome challenges associated with traditional hydroxyurea capsules, such as dosing inaccuracies and the need for refrigeration. The new dissolvable tablet is easy to administer, portable, and stable, making it ideal for rural and resource-limited settings.
Sickle cell disease affects about 120 million people globally, with 70% residing in Africa. Each year, approximately 240,000 children are born with the condition on the continent, yet less than 2% receive proper treatment. Tragically, between 50% and 80% of these children die before the age of five.
Scedamin offers a cost-effective and child-friendly alternative that could significantly improve survival rates and quality of life. Otieno emphasized their focus on affordability and accessibility, stating, “Our target markets are emerging regions where quality medication is often too expensive.”
Mudavadi, who previously attended the official launch of Scedamin during the UN General Assembly in 2024, reaffirmed Kenya’s support for international collaboration in health innovation. He was joined during his latest visit by West Virginia lawmakers and Kenya’s Ambassador to the US, David Kerich, in celebrating this milestone achievement.
